![Restoration of Li+ pathways in the [010] direction during direct regeneration for spent LiFePO4](http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5EE00641D)
.jpg)
Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis
Vincerx Pharma has found a fast fix for the uncertainty over its future. Recently left in limbo by the collapse of its reverse merger, the antibody-drug conjugate (ADC) developer has taken a step toward a new deal with an artificial intelligence company.
Vincerx Pharma has found a fast fix for the uncertainty over its future. Recently left in limbo by the collapse of its reverse merger, the antibody-drug conjugate (ADC) developer has taken a step toward a new deal with an artificial intelligence company.
